𝔖 Bobbio Scriptorium
✦   LIBER   ✦

p53 gene mutational spectra in hepatocellular carcinomas induced by 2-acetylaminofluorene and N-nitroso-2-acetylaminofluorene in rats

✍ Scribed by Yuan-Soon Ho; Hui-Teng Cheng; Ying-Jan Wang; Jen-Kun Lin


Book ID
102947829
Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
674 KB
Volume
13
Category
Article
ISSN
0899-1987

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

In this study, the mutation frequencies of the p53 gene in rat hepatocellular carcinomas (HCCs) induced by N‐nitroso‐2‐acetylaminofluorene (NO‐AAF) and 2‐acetylaminofluorene (AAF) were 19.23% (20 of 104) and 31.1% (33 of 106), respectively. Four noteworthy features of the mutation spectrums of the p53 gene in HCCs induced by both NO‐AAF and AAF were observed: (i) There was preferential clustering of mutations at exons 5–8 in both the NO‐AAF or AAF groups, (ii) Nearly all the mutations (98%) induced by NO‐AAF and AAF were point mutations, (iii) A high frequency of the p53 mutations were transition mutations, and the ratios of transition to transversion in the NO‐AAF and the AAF group were 13:6 and 21:12, respectively. Almost all the mutations were G→A transitions and guanosine was the major target base. (iv) The frequency and base location of p53 mutations were significantly associated with cancer cell differentiation. In poorly differentiated HCCs (58 individual tumor samples), mutations were detected in 24 of 58 samples (41.1%) and clustered mostly in exons 7 and 8 (19 of 24 samples), whereas in well‐differentiated HCCs (105 individual tumor samples), the incidence of mutations was low (one of 10 in the AAF group, 17 of 95 in the NO‐AAF group), and the mutations were located in exon 5 (11 of 18). The biological significance of these different mutational spectra among p53 genes deserves further investigation. © 1995 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Gene- and tissue-specificity of mutation
✍ Tao Chen; Roberta A. Mittelstaedt; Sharon D. Shelton; S. Balachandra Dass; Mugim 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

In a previous study, we found that treating transgenic Big Blue rats with the hepatocarcinogen N-hydroxy-2-acetylaminofluorene (N-OH-AAF) produced the same major DNA adduct in the target liver and the nontarget spleen lymphocytes and bone marrow cells, induced lacI mutants in the liver, and induced